SEIKAGAKU CORPORATION (4548.T) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

42.7x

EV/EBITDA

8.8x

Market Cap

JPY 38.50B

MomentumView details →

1D Return

−0.14%

YTD Return

−0.98%

RSI (14)

41.1

ValuationView details →

P/E (Fwd)

42.7x

EV/EBITDA

8.8x

Market Cap

JPY 38.50B

RSI (14)

41.1

MomentumView details →

1D Return

−0.14%

YTD Return

−0.98%

ProfitabilityView details →

Gross Margin

43.59%

Net Margin

4.02%

EBITDA Margin

3.61%

ROE (TTM)

1.96%

ROA (TTM)

1.71%

Asset Turnover

0.43x

GrowthView details →

Revenue YoY

−6.93%

EPS YoY

+21.24%

FCF YoY

—

Revenue CAGR 3Y

+3.08%

EPS CAGR 3Y

−12.65%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

5.34x

Quick Ratio

4.80x

Div Yield

4.26%

Div Rate

JPY 30.00

Div Growth 1Y

+0.00%

Financials snapshotView financials →

Revenue (TTM)

36.65B

Net Income (TTM)

1.47B

Op. CF (TTM)

—

Next earningsNov 10, 2026 →

Latest newsMore news →

Seikagaku Corporation announced its first-quarter results for April-June 2026, reporting an ordinary profit of 100 million yen, a turnaround from a 130 million yen loss in the same period last year.31d ago

Similar companies

Daito Pharmaceutical Co.,Ltd.4577.T Fuji Pharma Co.,Ltd.4554.T Cuorips Inc.4894.T MIZUHO MEDY CO.,LTD.4595.T Heartseed Inc.219A.T HEALIOS K.K.4593.T Find similar companies →

Latest newsMore news →

Seikagaku Corporation announced its first-quarter results for April-June 2026, reporting an ordinary profit of 100 million yen, a turnaround from a 130 million yen loss in the same period last year.31d ago